AUL
LLY icon

AlphaGrep UK Ltd’s Eli Lilly LLY Stock Holding History

AlphaGrep UK Ltd’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$531K Buy
577
+59
+11% +$59.8K 0.15% 221
2025
Q4 		$557K Buy
+518
New +$495K 0.19% 173

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AlphaGrep UK Ltd's LLY Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $59.8K and bringing the position to 577 shares worth $531K. The position accounts for 0.15% of the portfolio, ranked #221.

AlphaGrep UK Ltd first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $557K in Q4 2025. 4,368 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AlphaGrep UK Ltd held 577 shares of Eli Lilly worth $531K as of Q1 2026.
  • AlphaGrep UK Ltd bought 59 Eli Lilly shares in Q1 2026, an estimated $59.8K.
  • Eli Lilly made up 0.15% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #221 holding.
  • AlphaGrep UK Ltd first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's Eli Lilly position peaked at $557K in Q4 2025.
  • 4,368 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.